The anticancer gene ORCTL3 targets stearoyl-CoA desaturase-1 for tumour-specific apoptosis

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• ORCTL3 is identified as an anticancer gene capable of inducing tumor-specific cell death.
• Renal cell transformation triggers ORCTL3's cell death activity, irrespective of proliferation status.
• Stearoyl-CoA desaturase-1 (SCD1), involved in fatty acid metabolism, is identified as a key target of ORCTL3.

Purpose of the Study:

• To investigate the mechanism by which ORCTL3 induces tumor-specific cell death.
• To explore the role of stearoyl-CoA desaturase-1 (SCD1) in renal tumorigenesis.
• To evaluate the therapeutic potential of ORCTL3 in renal tumors.

Main Methods:

• Utilized isogenic renal cells to study ORCTL3's activity upon transformation.
• Investigated ORCTL3's interaction with stearoyl-CoA desaturase-1 (SCD1) using in vitro assays.
• Employed an adenovirus expressing ORCTL3 to assess its efficacy in vivo and ex vivo.

Main Results:

• ORCTL3 targets SCD1 in fatty acid metabolism for its cell death effect, mediated by transmembrane domains 3 and 4.
• SCD1 expression is upregulated in transformed renal cells, indicating its critical role in tumor progression.
• Adenovirus-mediated ORCTL3 expression inhibited renal tumor growth in vivo and destroyed patient-derived kidney tumor cells ex vivo.

Conclusions:

• Fatty acid metabolism, specifically targeting SCD1, represents a viable strategy for inducing tumor-specific apoptosis in renal tumors.
• ORCTL3 demonstrates significant potential as a therapeutic agent for renal cancer.
• The findings suggest ORCTL3 as a promising tool for targeting and eliminating kidney tumor cells.